170726-77-9

Basic information

• Product Name: t-butyl [5-(4-cyanophenyl)isoxazolin-3-yl]acetate
• CAS NO: 170726-77-9
• Molecular Weight: 286.331
• Mol File: 170726-77-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: t-butyl [5-(4-cyanophenyl)isoxazolin-3-yl]acetate(CAS DataBase Reference)
• NIST Chemistry Reference: t-butyl [5-(4-cyanophenyl)isoxazolin-3-yl]acetate(170726-77-9)
• EPA Substance Registry System: t-butyl [5-(4-cyanophenyl)isoxazolin-3-yl]acetate(170726-77-9)

Safety Data

• Hazardous Substances Data: 170726-77-9(Hazardous Substances Data)

Upstream product

• 190446-61-8 E/Z tert-Butyl ((hydroxyimino)methyl)acetate 
• 3435-51-6 4-ethenylbenzonitrile 
• 114085-57-3 C₇H₁₂ClNO₃ 

Downstream Products

• 190447-76-8 (S)-3-{2-[5-(4-{Amino-[(E)-tert-butoxycarbonylimino]-methyl}-phenyl)-4,5-dihydro-isoxazol-3-yl]-acetylamino}-2-butoxycarbonylamino-propionic acid methyl ester 
• 170726-80-4 [5-(4-{Amino-[(E)-tert-butoxycarbonylimino]-methyl}-phenyl)-4,5-dihydro-isoxazol-3-yl]-acetic acid 
• 1027837-58-6 [5-(4-Methoxycarbonimidoyl-phenyl)-4,5-dihydro-isoxazol-3-yl]-acetic acid tert-butyl ester 

Relevant articles and documents

Isoxazoline and isoxazole fibrinogen receptor antagonists

This invention relates to novel isoxazolines and isoxazoles which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex or the vitronectin receptor, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.